Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial
暂无分享,去创建一个
B. Gerstmayer | H. Volk | P. Reinke | O. Viklicky | B. Sawitzki | P. Miqueu | S. Tomiuk | E. Honsova | I. Týcová | P. Mrázová | S. Schmitz | E. Svobodová | U. Janssen | P. Hruba